INS and type 1 diabetes mellitus: MDI therapy is used by the majority of individuals with type 1 diabetes worldwide, but it is associated with frequent glycemic fluctuations, primarily due to variability in subcutaneous insulin absorption4 and insulin sensitivity, physical activities5, different food composition6, and stress, among other factors.